Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer
Abstract Precise biomarkers are needed to guide better diagnostics and therapeutics for basal-like breast cancer, for which DNA-dependent protein kinase catalytic subunit (DNA-PKcs) has been recently reported by the Clinical Proteomic Tumor Analysis Consortium as the most specific biomarker. We eval...
Guardado en:
Autores principales: | Karama Asleh, Nazia Riaz, Angela S. Cheng, Dongxia Gao, Samuel C. Y. Leung, Meenakshi Anurag, Torsten O. Nielsen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50da77342af4406d9748983cb7210dc1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine
por: Elisabeth S Stovgaard, et al.
Publicado: (2021) -
Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer
por: Nazia Riaz, et al.
Publicado: (2021) -
Proteomic maps of breast cancer subtypes
por: Stefka Tyanova, et al.
Publicado: (2016) -
Intrinsic timescales across the basal ganglia
por: Simon Nougaret, et al.
Publicado: (2021) -
Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status
por: Maria Rossing, et al.
Publicado: (2021)